Publication | Closed Access

Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase ii multicentre multinational study

Breast OncologyPhase IiMedicinePharmacologyGynecologyBreast CancerPharmacotherapyThird-line Hormonal TreatmentMultinational StudyOncologyRadiation OncologyEndocrine-related CancerMenopause Hormone Therapy